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症 例 報 告（第２３回若手奨励賞受賞論文）
クロピドグレル再投与により診断に至った薬剤性無顆粒球症の１例
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WBC ９００ /µL T-Bil １．０ mg/dL
Seg ５．７ % AST １３ U/L
Baso ０．８ % ALT ８ U/L
Eos ０．０ % LDH １４７ U/L
Mono ２．４ % BUN ５９．５ mg/dL
Lymph ９１．１ % Cre ２．８３ mg/dL
RBC ４３５ ×１０４／µL Na １４１．０ mEq/L
Hb １４．３ g／dL K ３．７４ mEq/L
























Figure２．骨髄組織診（A：Hematoxylin Eosin 染色，B：ASD 染色）；顆粒球系である ASD 陽性細胞は著明に減少していた。
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SUMMARY
Clopidogrel is an antiplatelet drug that is frequently used for coronary artery disease and
cerebrovascular disease. Hematologic adverse effect is less common with clopidogrel than ticlopi-
dine.
A５８-year-old man was treated with clopidogrel as antiplatelet therapy under the diagnosis of
cerebral infarction. Six weeks later, he was transported to our emergency department with fever,
sore throat and respiratory distress. Blood test showed marked leukopenia（neutrophil５１/mm３）.
A diagnosis of sepsis with acute epiglottitis and tonsillitis was made by blood culture and contrast-
enhanced computed tomography. Clopidogrel was discontinued due to thrombocytopenia. After
administration of antibacterial drugs and granulocyte colony-stimulating factor under ventilator in
the Intensive Care Unit, the infection improved with the recovery of the neutrophil count. Clopidog-
rel was restarted, but he developed leukopenia and high fever again２weeks later. Histopathology
of bone marrow revealed a marked decrease in myeloid cells, and he was diagnosed as drug-induced
agranulocytosis due to clopidogrel. After withdrawal of clopidogrel and supportive therapy for
febrile neutropenia, neutrophils recovered.
Although clopidogrel associated agranulocytosis is a very rare adverse event, it can be serious
and regular blood count monitoring is necessary after initiation of clopidogrel.
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